Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
29%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
PPH
27
HOLDINGS
42%
ALSO IN PJP
PJP
32
HOLDINGS
36%
ALSO IN PPH
SECTOR DRIFT (PPH minus PJP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 20.0% | 5.2% | 5.2% |
|
MERCK & CO. INC. | 9.9% | 4.8% | 4.8% |
|
ABBVIE INC | 4.7% | 5.1% | 4.7% |
|
PFIZER INC | 4.5% | 4.9% | 4.5% |
|
JOHNSON & JOHNSON | 4.5% | 5.0% | 4.5% |
PPH Overweight Relative to PJP
|
ELI LILLY & CO | 14.7% |
 |
NOVARTIS AG-ADR | 10.4% |
 |
NOVO-NORDISK A/S-SPONS ADR | 5.4% |
|
MERCK & CO. INC. | 5.1% |
|
MCKESSON CORP | 4.5% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | 4.3% |
 |
SANOFI-AVENTIS-ADR | 4.0% |
|
ASTRAZENECA PLC-SPONS ADR | 3.8% |
|
CENCORA INC | 3.6% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 3.1% |
PPH Underweight Relative to PJP
|
ABBOTT LABORATORIES | -5.2% |
|
AMGEN INC | -5.1% |
|
GILEAD SCIENCES INC | -4.7% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -3.6% |
|
TRAVERE THERAPEUTICS, INC. | -3.5% |
|
LIQUIDIA TECHNOLOGIES, INC. | -3.4% |
|
LIGAND PHARMACEUTICALS-CL B | -3.3% |
|
OCULAR THERAPEUTIX INC | -3.2% |
|
CORCEPT THERAPEUTICS INC | -3.2% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -3.2% |